Website Dedicated to Platform of Saudi WTO Director General Candidate

Saudi Arabia’s candidate for the position of Director General of the World Trade Organization (WTO) Mohammad Al-Tuwaijri. (AFP)
Saudi Arabia’s candidate for the position of Director General of the World Trade Organization (WTO) Mohammad Al-Tuwaijri. (AFP)
TT

Website Dedicated to Platform of Saudi WTO Director General Candidate

Saudi Arabia’s candidate for the position of Director General of the World Trade Organization (WTO) Mohammad Al-Tuwaijri. (AFP)
Saudi Arabia’s candidate for the position of Director General of the World Trade Organization (WTO) Mohammad Al-Tuwaijri. (AFP)

Saudi Arabia’s candidate for the position of Director General of the World Trade Organization (WTO) Mohammad Al-Tuwaijri unveiled a website aimed at promoting his platform for heading the global organization.

The portal is available in English, Persian, Spanish and Arabic and is topped with a banner reading: “Trade is the foundation of peace and development.”

“Its sole goal is to establish a global system that adheres to laws. The WTO must now, more than ever, work on bolstering global cooperation.”

Separately, in remarks to Arrajol magazine, Tuwaijiri said the position of WTO chief, at the time of the coronavirus, is one of the most important internationally because it supports global trade and facilitates activities between nations.

On his vision for the organization, he said the WTO is need of great structural and administrative reform. This requires the cooperation of all of its members.

He spoke of a comprehensive plan he will submit to members that envisages the establishment of a strong and dynamic organization that can resolve all global trade problems, while remaining prepared for the 21st century and the challenges it has in store.

On how he will deal with the impact of the coronavirus pandemic on the global economy and trade, Tuwaijiri noted that repercussions will vary from one country to the other, all of which ultimately depend on the state of the global economy, infrastructure and trade.

Tackling the crisis lies in practical and realistic solutions that are based on facts and comprehensive studies and discussions among WTO members, he continued.

The WTO must be the main reference, which is why talks are focusing on sustainable development that should ensure that no wide gaps remain in the global trade system, he continued.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.